Identification of biomarkers of impaired sensory profiles among autistic patients

PLoS ONE

Volumn 11, Issue 11, 2016, Pages

  El Ansary, Afaf ^a,c   Hassan, Wail M ^d   Qasem, Hanan ^b   Das, Undurti N ^e,f  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c NATIONAL RESEARCH CENTRE   (Egypt)

^d UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^e UND Life Sciences   (United States)

^f GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; DUAL SPECIFICITY MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; MICROSOMAL PROSTAGLANDIN SYNTHASE E 1; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; 8-EPI-PROSTAGLANDIN F2ALPHA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHOLIPASE A2; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN F2 ALPHA;

ADOLESCENT; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; MULTIDIMENSIONAL SCALING; MULTIPLE REGRESSION; PRINCIPAL COMPONENT ANALYSIS; STEPWISEMULTIPLE REGRESSION; ANALOGS AND DERIVATIVES; COGNITIVE DEFECT; FEMALE; MALE; METABOLISM; PRESCHOOL CHILD;

ADOLESCENT; AUTISTIC DISORDER; BIOMARKERS; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; CYCLOOXYGENASE 2; DINOPROST; DINOPROSTONE; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MAP KINASE KINASE 1; NF-KAPPA B; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLSERINES; PHOSPHOLIPASES A2; PROSTAGLANDIN-E SYNTHASES;

EID: 84994479580     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164153     Document Type: Article

References (43)

1. Geschwind DH (2009) Advances in autism. Annu Rev Med 60: 367-380. doi: 10.1146/annurev.med.60.053107.121225 PMID: 19630577
2. Silver WG, Rapin I (2012) Neurobiological basis of autism. PediatrClin North Am 59: 45-61, x. doi: 10.1016/j.pcl.2011.10.010 PMID: 22284792
3. Ganz M (2006) The Costs of Autism In Moldin SO and Rubenstein JLR (eds), Understanding Autism: from Basic Neuroscience to Treatment. Boca Raton: CRC Press.
4. Kohane IS, McMurry A, Weber G, MacFadden D, Rappaport L, Kunkel L, et al. (2012) The comorbidity burden of children and young adults with autism spectrum disorders. PloS one 7: e33224. doi: 10.1371/journal.pone.0033224 PMID: 22511918
5. Gadad BS, Hewitson L, Young KA, German DC (2013) Neuropathology and animal models of autism: genetic and environmental factors. Autism Res Treat 2013: 731935. doi: 10.1155/2013/731935 PMID: 24151553
6. Gillberg C, Coleman M (2000) The biology of the autistic syndromes: Cambridge University Press.
7. Mandell D (2011) The heterogeneity in clinical presentation among individuals on the autism spectrum is a remarkably puzzling facet of this set of disorders. Autism 15: 259-261. PMID: 21815289
8. Filipek P, Accardo P, Ashwal S, Baranek G, Cook E, Dawson G, et al. (2000) Practice parameter: Screening and diagnosis of autism Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 55: 468-479. PMID: 10953176
9. Perry A, Condillac RA, Freeman NL, Dunn-Geier J, Belair J (2005) Multi-site study of the Childhood Autism Rating Scale (CARS) in five clinical groups of young children. J Autism Dev Disord 35: 625-634. doi: 10.1007/s10803-005-0006-9 PMID: 16172810
10. Constantino JN, Gruber CP (2007) Social responsiveness scale (SRS): Western Psychological Services Los Angeles, CA.
11. Dunn W (1999) The Sensory Profile: Examiner's manual. San Antonio, T.X The Psychological Corporation.
12. Szatmari P (2011) New recommendations on autism spectrum disorder. BMJ 342.
13. Dunn W, Westman K (1997) The Sensory Profile: The performance of a national sample of children without disabilities. American Journal of Occupational Therapy 51: 25-34. PMID: 8978860
14. Baranek GT (2002) Efficacy of sensory and motor interventions for children with autism. J Autism Dev Disord 32: 397-422. PMID: 12463517
15. Kientz MA, Dunn W (1997) A comparison of the performance of children with and without autism on the Sensory Profile. American Journal of Occupational Therapy 51: 530-537. PMID: 9242859
16. LeCouteur A, Rutter M, Lord C, Rios P, Robertson S, Holdgrafer M, et al. (1989) Autism diagnostic interview: A standardized investigator-based instrument. J Autism Dev Disord 19: 363-387. PMID: 2793783
17. Watling RL, Deitz J, White O (2001) Comparison of Sensory Profile scores of young children with and without autism spectrum disorders. American Journal of Occupational Therapy 55: 416-423. PMID: 11723986
18. Tomchek SD, Dunn W (2007) Sensory processing in children with and without autism: a comparative study using the short sensory profile. Am J Occup Ther 61: 190-200. PMID: 17436841
19. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Canadian journal of biochemistry and physiology 37: 911-917. doi: 10.1139/o59-099 PMID: 13671378
20. O'connor BP (2000) SPSS and SAS programs for determining the number of components using parallel analysis and Velicer's MAP test. Behavior research methods, instruments, & computers 32: 396-402.
21. Hu VW, Steinberg ME (2009) Novel clustering of items from the Autism Diagnostic Interview-Revised to define phenotypes within autism spectrum disorders. Autism Research 2: 67-77. doi: 10.1002/aur.72 PMID: 19455643
22. Subramanian M, Timmerman CK, Schwartz JL, Pham DL, Meffert MK (2015) Characterizing autism spectrum disorders by key biochemical pathways. Frontiers in neuroscience 9.
23. Murakami M, Kudo I (2002) Phospholipase A2. Journal of Biochemistry 131: 285-292. PMID: 11872155
24. Bell JG, MacKinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen AC (2004) Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins, leukotrienes, and essential fatty acids 71: 201-204. doi: 10.1016/j.plefa.2004.03.008 PMID: 15301788
25. Tostes MH, Teixeira HC, Gattaz WF, Brandao MA, Raposo NR (2012) Altered neurotrophin, neuropeptide, cytokines and nitric oxide levels in autism. Pharmacopsychiatry 45: 241-243. doi: 10.1055/s-0032-1301914 PMID: 22426848
26. Dubois A, Rattaz C, Pry R, Baghdadli A (2009) [Autism and pain - a literature review]. Pain research & management: the journal of the Canadian Pain Society = journal de la societe canadienne pour le traitement de la douleur 15: 245-253.
27. Gorrindo P, Williams KC, Lee EB, Walker LS, McGrew SG, Levitt P (2012) Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors. Autism Research 5: 101-108. doi: 10.1002/aur.237 PMID: 22511450
28. Wallace JL (2001) Prostaglandin biology in inflammatory bowel disease. Gastroenterology clinics of North America 30: 971-980. PMID: 11764538
29. Lawrence G (2010) The fats of life: essential fatty acids in health and disease.
30. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, et al. (1998) Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391: 281-285. doi: 10.1038/34651 PMID: 9440691
31. Bezzi P, Volterra A (2001) A neuron-glia signalling network in the active brain. Current opinion in neurobiology 11: 387-394. PMID: 11399439
32. Zonta M, Sebelin A, Gobbo S, Fellin T, Pozzan T, Carmignoto G (2003) Glutamate-mediated cytosolic calcium oscillations regulate a pulsatile prostaglandin release from cultured rat astrocytes. The Journal of physiology 553: 407-414. doi: 10.1113/jphysiol.2003.046706 PMID: 14500777
33. Ashwood P, Wills S, Van de Water J (2006) The immune response in autism: a new frontier for autism research. Journal of leukocyte biology 80: 1-15. doi: 10.1189/jlb.1205707 PMID: 16698940
34. Yao Y, Walsh WJ, McGinnis WR, Praticô D (2006) Altered vascular phenotype in autism: correlation with oxidative stress. Archives of neurology 63: 1161-1164. doi: 10.1001/archneur.63.8.1161 PMID: 16908745
35. Gorrindo P, Lane CJ, Lee EB, McLaughlin B, Levitt P (2013) Enrichment of Elevated Plasma F 2t-Isoprostane Levels in Individuals with Autism Who Are Stratified by Presence of Gastrointestinal Dysfunction. PloS one 8: e68444. doi: 10.1371/journal.pone.0068444 PMID: 23844202
36. Dunn W (2001) The sensations of everyday life: Empirical, theoretical, and pragmatic considerations. American Journal of Occupational Therapy 55: 608-620. PMID: 12959225
37. Das UN (2013) Autism as a disorder of deficiency of brain-derived neurotrophic factor and altered metabolism of polyunsaturated fatty acids. Nutrition 29: 1175-1185. doi: 10.1016/j.nut.2013.01.012 PMID: 23911220
38. Das UN (2013) Nutritional factors in the pathobiology of autism. Nutrition 29: 1066-1069. doi: 10.1016/j.nut.2012.11.013 PMID: 23410630
39. Mostafa GA, El-Hadidi ES, Hewedi DH, Abdou MM (2010) Oxidative stress in Egyptian children with autism: relation to autoimmunity. Journal of neuroimmunology 219: 114-118. doi: 10.1016/j.jneuroim.2009.12.003 PMID: 20036015
40. Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK (1999) Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. The Journal of pediatrics 134: 607-613. PMID: 10228297
41. Ahmad SF, Zoheir KM, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, et al. (2016) Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism. Molecular neurobiology.
42. Breece E, Paciotti B, Nordahl CW, Ozonoff S, Van de Water JA, Rogers SJ, et al. (2013) Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors. Brain, behavior, and immunity 31: 69-75. doi: 10.1016/j.bbi.2012.10.006 PMID: 23063420
43. Qasem H, Al-Ayadhi L, El-Ansary A (2016) Cysteinyl leukotriene correlated with 8-isoprostane levels as predictive biomarkers for sensory dysfunction in autism. Lipids in health and disease 15: 1.